Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy

Author: Avoranta S. Tuulia   Korkeila Eija A.   Minn Heikki R. I.   Syrjänen Kari J.   Pyrhönen Seppo O.   Sundström Jari T. T.  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.50, Iss.8, 2011-11, pp. : 1158-1166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content